Kindly Md, INC Form 4 insider transactions

David F Bailey, Chief Executive Officer, a Director and 10% owner of Kindly MD, Inc., received 108,200,628 shares of common stock on February 20, 2026.

Tyler Matthew Evans, Chief Investment Officer and a Director of Kindly MD, Inc., received 17,841,993 shares of common stock on February 20, 2026.

Mark W Yusko, a Director of Kindly MD, Inc., received 10,623 shares of common stock on August 21, 2026.

Gregory Elias Xethalis, a Director of Kindly MD, Inc., received 10,623 shares of common stock on August 21, 2026.

Perianne Boring Mcnulty, a Director of Kindly MD, Inc., received 10,623 shares of common stock on August 21, 2026.

Teresa S Gendron, Chief Financial Officer of Kindly MD, Inc., received 70,821 shares of common stock on August 27, 2026.

John Merritt Dalton, Chief Accounting Officer of Kindly MD, Inc., received 42,492 shares of common stock on August 27, 2026.

Charles Phillip Blackburn, a Director of Kindly MD, Inc., received 10,623 shares of common stock on August 21, 2026.

Tyler Matthew Evans, Chief Investment Officer and a Director of Kindly MD, Inc., sold 982 shares of common stock on September 15, 2026 for $7.63 per share.

Calli Sullivan Bailey, a 10% owner of Kindly MD, Inc., reported a transaction in 3,844 shares of common stock on August 25, 2026.

Teresa S Gendron, Chief Financial Officer of Kindly MD, Inc., received 70,821 shares of common stock on August 27, 2026.

John Merritt Dalton, Chief Accounting Officer of Kindly MD, Inc., received 42,492 shares of common stock on August 27, 2026.

Mark W Yusko, a Director of Kindly MD, Inc., received 10,623 shares of common stock on August 21, 2026.

Gregory Elias Xethalis, a Director of Kindly MD, Inc., received 10,623 shares of common stock on August 21, 2026.

Perianne Boring Mcnulty, a Director of Kindly MD, Inc., received 10,623 shares of common stock on August 21, 2026.

Charles Phillip Blackburn, a Director of Kindly MD, Inc., received 10,623 shares of common stock on August 21, 2026.

Tyler Matthew Evans, Chief Investment Officer and a Director of Kindly MD, Inc., reported multiple transactions in common stock on August 21, 2026.

Amanda Fabiano, Chief Operating Officer of Kindly MD, Inc., received 70,821 shares of common stock on August 21, 2026.

David F Bailey, Chief Executive Officer, a Director and 10% owner of Kindly MD, Inc., reported multiple transactions in common stock on August 21, 2026.

David F Bailey, Chief Executive Officer, a Director and 10% owner of Kindly MD, Inc., purchased 36,986 shares of common stock on August 19, 2026.

David F Bailey, Chief Executive Officer, a Director and 10% owner of Kindly MD, Inc., purchased 4,918 shares of common stock on August 18, 2026.

Nakamoto Inc. CEO David F. Bailey acquired 55,115 shares of common stock in open market transactions.

CEO David Bailey acquired 136,333 shares of Nakamoto Inc. common stock through open market purchases between May 26 and May 27, 2026.

Nakamoto Inc.'s Chief Investment Officer, Tyler Matthew Evans, was granted 600,000 shares of common stock as part of his 2025 bonus payment.

Nakamoto Inc.'s Chief Investment Officer, Tyler Matthew Evans, filed an amended Form 4 to correct a scrivener's error regarding his beneficial ownership of common stock and derivative securities following recent mergers.

Nakamoto Inc.'s Chief Investment Officer, Tyler Matthew Evans, significantly increased his beneficial ownership of common stock and stock options following two merger agreements.

Nakamoto Inc. CEO David F. Bailey significantly increased his beneficial ownership of common stock following two merger agreements.

Nakamoto Inc.'s Chief Commercial Officer, Andrew John Creighton, acquired 1,685,500 fully vested stock options at an exercise price of $0.43, assumed as part of a recent merger.

Kindly MD, Inc. Chief Accounting Officer John Merritt Dalton was granted 1,574,803 restricted stock units, vesting over four years.

Kindly MD, Inc.'s Chief Financial Officer, Teresa S. Gendron, was granted 2,624,671 restricted stock units, vesting over four years.